welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.
expertly curated content related to this topic
-
polyposis (polypeople)FAP is an inherited condition which main...
-
David M. Kastenberg, MDInterests: Inherited Colorectal Cancer -...
-
Todd SpurrierThe mission of DESTINATION X RIDE (DXR) ...
-
Familial Adenomatous Polyposis in Pediatrics: Natural History, Emerging Surveillance and Management Protocols, Chemo...Familial adenomatous polyposis (FAP) is ...
-
Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisRATIONALE: Exisulind may be effectiv...
-
stolen colonMy name is Steph. At the age of 29 I was...
-
Diane L. Broome, MDDiane L. Broome, MD, is a Physician and ...